Thursday, November 12, 2026
Title: Obesity-Associated Nitrosative Stress Impairs Hepatic IDE Activity and Insulin Metabolism
Early in obesity, impaired insulin action and altered insulin clearance contribute to systemic hyperinsulinemia, increasing the risk of metabolic and cardiovascular complications. The liver plays a central role in maintaining insulin homeostasis by regulating insulin clearance and degradation. Insulin-degrading enzyme (IDE) is an important protease involved in this process, yet the mechanisms regulating its activity during obesity remain poorly understood.
Previous work from our laboratory demonstrated that obesity promotes protein S-nitrosylation (SNO), a reversible modification associated with nitrosative stress that can alter protein function. Increased hepatic S-nitrosylation has been linked to inflammation and insulin resistance, suggesting that this modification may also affect insulin metabolism. Based on these findings, my dissertation investigates whether obesity-associated S-nitrosylation impairs IDE function and contributes to altered hepatic insulin metabolism.
Our findings identify IDE as a target of S-nitrosylation during obesity, with increased IDE SNO associated with reduced enzymatic activity in the liver. We further identified Cys171 as a functionally important residue whose substitution preserved IDE activity and improved glucose homeostasis in obese mice. Additionally, our findings suggest that IDE may participate in intracellular processes beyond its established proteolytic function, including interactions with proteins involved in intracellular trafficking. Together, these findings identify S-nitrosylation as a previously unrecognized mechanism regulating hepatic IDE activity and provide new insights into how obesity-associated nitrosative stress contributes to impaired insulin metabolism and metabolic dysfunction.
Congratulations Juan!